Cargando…
Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith–Lemli–Opitz Syndrome
Smith–Lemli–Opitz Syndrome (SLOS) results from mutations in the gene encoding the enzyme DHCR7, which catalyzes conversion of 7-dehydrocholesterol (7DHC) to cholesterol (CHOL). Rats treated with a DHCR7 inhibitor serve as a SLOS animal model, and exhibit progressive photoreceptor-specific cell death...
Autores principales: | Pfeffer, Bruce A., Xu, Libin, Fliesler, Steven J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956713/ https://www.ncbi.nlm.nih.gov/pubmed/33652836 http://dx.doi.org/10.3390/ijms22052339 |
Ejemplares similares
-
Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention
por: Fliesler, Steven J., et al.
Publicado: (2018) -
Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome
por: Fliesler, Steven J., et al.
Publicado: (2018) -
7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome
por: Tomita, Hideaki, et al.
Publicado: (2022) -
Author Correction: Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome
por: Fliesler, Steven J., et al.
Publicado: (2018) -
Smith-Lemli-Opitz-syndrome
por: Gedam, Rachana, et al.
Publicado: (2012)